tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Compare Arcutis Biotherapeutics (ARQT) vs. Competitors

Compare
950 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arcutis Biotherapeutics
$25.85
$3.23B
-72.92
88.00%
6 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$27.87
$2.54B
-25.70
50.89%
11 Buy
2 Hold
0 Sell
Strong Buy
Disc Medicine
$70.93
$2.68B
-13.24
18.32%
12 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$36.22
$2.10B
11.41
-6.02%
4 Buy
0 Hold
1 Sell
Moderate Buy
Tarsus Pharmaceuticals
$71.14
$3.13B
-35.33
51.62%
6 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$4.67
$2.41B
-2.58
-27.03%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARQT
Arcutis Biotherapeutics
25.85
12.77
97.63%
TVTX
Travere Therapeutics
27.87
8.41
43.22%
IRON
Disc Medicine
70.93
10.41
17.20%
HRMY
Harmony Biosciences Holdings
36.22
-4.24
-10.48%
TARS
Tarsus Pharmaceuticals
71.14
24.40
52.20%
RXRX
Recursion Pharmaceuticals
4.67
-2.21
-32.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts